Acasti Pharma Inc. (ACST)
NASDAQ: ACST · IEX Real-Time Price · USD
3.030
+0.070 (2.36%)
At close: May 2, 2024, 4:00 PM
2.960
-0.070 (-2.31%)
After-hours: May 3, 2024, 4:00 PM EDT
Acasti Pharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$6.00
Upside
+98.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +98.02% | Feb 7, 2024 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +395.05% | Feb 15, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +395.05% | Dec 19, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +375.25% | Dec 15, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $36 | Buy | Initiates | $36 | +1,088.12% | Dec 22, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates $36 | Buy | Initiates | $36 | +1,088.12% | Dec 21, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 2, 2020 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 1, 2020 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 1, 2020 |
| B. Riley Securities | B. Riley Securities | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Jul 6, 2020 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | May 6, 2020 |